Oct 1, 2026 · 7 min
European stocks diverge as property, pharma and cities compete for growth
AG Barr Drops, LandSec Falls, Sanofi Gains
The episode links immediate market reactions to longer-term questions about corporate strategy, drug development and how fast-growing cities plan for expansion.
- 1AG Barr fell after Berenberg cut the soft-drinks maker from buy to hold and lowered its price target.
- 2Landsec plans a £500 million share sale to help fund its £516 million Metrocentre acquisition.
- 3Sanofi expanded its Regeneron partnership while Dubai’s planning model frames technology as a tool for urban growth.
Don't miss
Sanofi’s expanded Regeneron partnership stands out as the episode’s clearest positive market development, covering four antibody drugs.
The brief
The episode opens with a question about rapidly growing cities: can long-term planning, artificial intelligence and innovation make urban development more resilient?
The market report then tracks three distinct corporate stories: AG Barr falls after a Berenberg downgrade, Landsec prepares a £500 million share sale, and Sanofi expands its Regeneron partnership.
Landsec’s planned fundraising is tied to a £516 million purchase of the Metrocentre near Newcastle, making capital allocation central to the property story.
Sanofi’s agreement to co-develop and commercialize four antibody drugs with Regeneron is presented as a significant win and a positive step for its longer-term outlook.
The closing discussion returns to urban innovation, examining Dubai’s rapid population growth and how technology can serve as a growth engine within a broader development blueprint.
What was said on this episode
10 statements · 6 positive · 2 negative · 2 neutral
AG Barr shares fell as much as 4.7% during the morning.
“Shares down as much as about 4.7% this morning.”
Listen at 0:47
Landsec is reducing office exposure and increasing retail-property holdings.
“Landsec in general has been reducing exposure to offices and lower yielding offices and buying up retail properties.”
Listen at 2:58
Metrocentre’s acquisition price is about half its estimated rebuilding cost.
“that acquisition price of £516 million, that would only represent about half of what it would cost to rebuild Metro Centre.”
Listen at 3:19
Sanofi will need to replace income when the prior drug patent expires in the early 2030s.
“when that patent begins to expire in early 2030s, they then need to replace that income.”
Listen at 4:19
Sanofi shares rose about 3.7% in Paris after the partnership news.
“shares rising on the back of that, they're up about 3.7% in Paris.”
Listen at 4:27
AI will compress processes in smart-city development.
“AI will allow in the smart city space to compress a lot of things.”
Listen at 5:18
AI will change the speed of smart-city processes.
“The speed will change.”
Listen at 5:22
Dubai has learned substantially from its sudden population increase.
“I think Dubai has learned a lot from a sudden increase in population”
Listen at 5:37
Dubai responded very effectively to its sudden population increase.
“I think they reacted very well to it.”
Listen at 5:43
Dubai has a long-term urban-planning vision.
“They have a long-term urban planning vision”
Listen at 5:46
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Nathan Hager
Berenberg Bank
MetrocentreBooks & mentions
Listen to the full episode and explore every guest, topic, and moment on PodLume.